Completion of Global3D Acquisition

Medical technology company Singular Health Group Ltd (ASX: SHG) (“Singular Health”, or “the Company”) is pleased to advise that it has completed the acquisition of the assets of Global3D Pty Ltd (“Global3D”) as previously announced on 6 December 2022. The acquisition is the culmination of over two years of working together with Global3D to investigate and develop enhanced software, technology and 3D printing processes for a range of medical devices, including customised ankle foot orthotics and individualised prosthetics.

Singular Health’s wholly owned subsidiary, Singular 3DP Pty Ltd (“Singular 3DP”) is focused on the growth of the existing capabilities of Global3D including ongoing marketing of the Global3D brand. Singular 3DP is also vertically integrating the Company’s 3Dicom medical imaging software into Global3D’s sales and production process.

Commenting on the transaction, Singular Health’s CEO, Thomas Hanly, said:

“We are excited to have concluded the transaction with Global3D and to welcome them to the Singular Health Group. We have made great progress during recent months to position the Company for success in 2023 and we look forward to updating the market and our shareholders in due course.”

This announcement is authorised for release by the Board of Directors of the Company.

Click here for the full ASX Release

This article includes content from Singular Health Group Limited, licensed for the purpose of publishing on Investing News Australia. This article does not constitute financial product advice. It is your responsibility to perform proper due diligence before acting upon any information provided here. Please refer to our full disclaimer here.